Ret Fusion-positive Solid Tumors
📧 Sign up to get email alerts when something new happens for Ret Fusion-positive Solid Tumors.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-11-20FDA Approved: RETEVMO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for RETEVMO (selpercatinib) submitted by Eli Lilly and Company, expanding its approved indicatio…